Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Urogynecological Care in Gynecological Oncology Patients

Int Urogynecol J; ePub 2016 Nov 17; Doyle, et al

The ability to provide treatment for gynecological cancer and pelvic floor disorders concurrently has the potential to improve the quality of life for gynecological oncology patients, a recent study found. A pelvic floor dysfunction screening questionnaire was given to new patients presenting to a university-based gynecological oncology practice between August 1, 2010, and August 31, 2012. Those indicating symptoms related to pelvic floor dysfunction were offered urogynecological evaluations. Researchers found:

  • Of 546 survey reviews, 236 (42.0%) patients reported being bothered by pelvic floor dysfunction symptoms.
  • However, only 6.7% wanted a referral for a urogynecological evaluation, and 93.2% declined an evaluation.
  • The most frequently cited barrier to care among patients reporting moderate to severe bother from pelvic floor symptoms was feeling overwhelmed with the current medical situation (28%).
  • Other barriers included a previous evaluation (14%), financial concerns (6.9%), and the belief that oncological treatment would cure pelvic floor symptoms (6%).


Doyle PJ, Thomas SG, Buchsbaum GM. Barriers to urogynecological care in a population of gynecological oncology patients. [Published online ahead of print November 17, 2016]. Int Urogynecol J. doi:10.1007/s00192-016-3204-4.